0001698865-23-000001.txt : 20230208 0001698865-23-000001.hdr.sgml : 20230208 20230208145618 ACCESSION NUMBER: 0001698865-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 EFFECTIVENESS DATE: 20230208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accure Acne, Inc. CENTRAL INDEX KEY: 0001698865 IRS NUMBER: 814819638 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-472975 FILM NUMBER: 23598730 BUSINESS ADDRESS: STREET 1: 384 INVERNESS PARKWAY, #125 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-886-6125 MAIL ADDRESS: STREET 1: 384 INVERNESS PARKWAY, #125 CITY: ENGLEWOOD STATE: CO ZIP: 80112 D 1 primary_doc.xml X0708 D LIVE 0001698865 Accure Acne, Inc. 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 9706882498 DELAWARE None None Corporation true Karl Nicholls 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Executive Officer Christopher Carlton 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Executive Officer Director Edward Barbera 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Director Samuel E Navarro 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Director Jeffrey O'Donnell 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Director Other Health Care Decline to Disclose 06b false 2023-01-26 false true true true true false 25000 Maxim Group LLC 120708 None None 300 Park Ave 16th Floor New York NY NEW YORK 10022 All States false 20000000 7951197 12048803 false 20 362500 true 0 10% of total cash consideration received by the Company. Also issuance of warrants to purchase equity equal to 10% of total securities being sold or issued. 0 true false Accure Acne, Inc. /s/ Karl Nicholls Karl Nicholls Chief Financial Officer 2023-02-08